Improved primary transplant success rates using a triple regimen of cyclosporine microemulsion, mycophenolate mofetil and prednisone

Transplant Proc. 2001 Aug;33(5):2776-7. doi: 10.1016/s0041-1345(01)02187-x.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Acyclovir / therapeutic use
  • Antiviral Agents / therapeutic use
  • Cadaver
  • Cyclosporine / administration & dosage
  • Cyclosporine / therapeutic use*
  • Cytomegalovirus Infections / drug therapy
  • Drug Therapy, Combination
  • Emulsions
  • Graft Rejection / drug therapy
  • Histocompatibility Testing
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology
  • Kidney Transplantation / physiology*
  • Living Donors
  • Muromonab-CD3 / therapeutic use
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use*
  • Prednisone / therapeutic use*
  • Reoperation / statistics & numerical data
  • Time Factors
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Emulsions
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Cyclosporine
  • Mycophenolic Acid
  • Prednisone
  • Acyclovir